12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

rhNGF recombinant human nerve growth factor regulatory update

Dompe said the European Commission granted Orphan Drug designation for its rhNGF to treat retinitis pigmentosa. The...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >